アジア太平洋地域のリアルワールドエビデンスソリューションの市場規模、シェア、産業動向分析レポート：コンポーネント別、治療分野別、エンドユーザー別、用途別、国別、成長予測、2022年～2028年

アジア太平洋地域のリアルワールドエビデンスソリューション市場は、予測期間中（2022年～2028年）にCAGR9.0%の市場成長を遂げると予想されています。

この情報は、優れた結果を称える品質ベースの償還スキームを改善し、支払者と消費者がより多くの情報を得た上で保険適用について議論することを支援することができます。患者登録、製品登録、クレーム登録のような臨床登録は、それに加えてRWDの豊富な情報源です。これらは、RWEを作成し、市販後の調査やサーベイランスを促進するために活用するための不可欠なリソースです。

規制・償還の意思決定にRWEを活用することは、アジア太平洋地域の政府や規制当局が様々なレベルで行っていることです。RWEの利点と能力を示すために、いくつかはすでに正式な助言を発表し、パイロットプロジェクトに移行しています。また、まだそれらのアプローチの初期段階にあるものもあります。中国ではヘルスケアの意思決定をサポートする実証的データの必要性が高まっているため、多くの新しいデータソースが開発されました。医療経済学、疫学、アウトカム研究では、現在利用可能な実世界のヘルスケアデータソースを包括的に評価したわけではありません。このように、ヘルスケア分野におけるリアルワールドエビデンスの活用が進んでいることが、アジア太平洋地域のリアルワールドエビデンスソリューション市場の成長を牽引しています。

中国市場は、2021年にアジア太平洋地域の国別リアルワールドエビデンスソリューション市場を独占し、2028年まで支配的な市場であり続け、それにより2028年までに46億5770万米ドルの市場価値を達成すると推定されます。また、インド市場は2022年～2028年の間にCAGR9.7%で成長すると予測されています。

コンポーネントに基づき、市場はサービスおよびデータセットに区分されます。治療分野別では、腫瘍学、循環器学、神経学、糖尿病、呼吸器学、その他に区分されます。エンドユーザーに基づいて、市場はヘルスケア企業、ヘルスケアペイヤー、ヘルスケアプロバイダ、その他に区分されます。用途別に見ると、市場は医薬品開発・承認、医療機器開発・承認、償還・補償・規制上の意思決定、市場安全・有害事象モニタリングに区分されます。国別に見ると、市場は中国、日本、インド、韓国、シンガポール、マレーシア、その他アジア太平洋地域に区分されます。

目次

第1章 市場の範囲と調査手法

• 市場の定義
• 目的
• 市場規模
• セグメンテーション
  • アジア太平洋地域のリアルワールドエビデンスソリューション市場、コンポーネント別
  • アジア太平洋地域のリアルワールドエビデンスソリューション市場、治療分野別
  • アジア太平洋地域のリアルワールドエビデンスソリューション市場：エンドユーザー別
  • アジア太平洋地域のリアルワールドエビデンスソリューション市場：用途別
  • アジア太平洋地域のリアルワールドエビデンスソリューション市場：国別
• 調査手法

第2章 市場概要

• イントロダクション
  • 概要説明
    • 市場のシナリオと構成
• 市場に影響を与える主な要因
  • 市場の促進要因
  • 市場の抑制要因

第3章 実環境証拠ソリューション市場で展開されている戦略

第4章 アジア太平洋地域のリアルワールドエビデンスソリューション市場：コンポーネント別

• アジア太平洋地域のサービス市場：国別
• アジア太平洋地域のデータセット市場：国別

第5章 アジア太平洋地域のリアルワールドエビデンスソリューション市場：治療領域別

• アジア太平洋地域の腫瘍学市場：国別
• アジア太平洋地域の心臓病学市場の国別推移
• アジア太平洋地域の神経学市場の国別推移
• アジア太平洋地域の糖尿病市場：国別
• アジア太平洋地域の呼吸器系市場：国別
• アジア太平洋地域のその他の市場：国別

第6章 アジア太平洋地域のリアルワールドエビデンスソリューションのエンドユーザー別市場

• アジア太平洋地域のヘルスケア企業市場：国別
• アジア太平洋地域のヘルスケアペイヤー市場：国別
• アジア太平洋地域のヘルスケアプロバイダの国別市場
• アジア太平洋地域のその他の市場：国別

第7章：アジア太平洋地域のリアルワールドエビデンスソリューションの用途別市場

• アジア太平洋地域の医薬品開発・承認市場：国別
• アジア太平洋地域の医療機器開発・承認市場：国別
• アジア太平洋地域の償還・補償・規制当局別意思決定市場：国別
• アジア太平洋地域の市販後安全性・有害事象モニタリング市場：国別

第8章 アジア太平洋地域のリアルワールドエビデンスソリューションの国別市場

• 中国リアルワールドエビデンスソリューション市場
  • 中国リアルワールドエビデンスソリューションのコンポーネント別市場
  • 中国のリアルワールドエビデンスソリューション市場：治療分野別
  • 中国のリアルワールドエビデンスソリューション市場：エンドユーザー別
  • 中国のリアルワールドエビデンスソリューション市場：用途別
• 日本のリアルワールドエビデンスソリューション市場
  • リアルワールドエビデンスソリューションの日本市場：コンポーネント別
  • リアルワールドエビデンスソリューションの日本市場：治療分野別
  • リアルワールドエビデンスソリューションの日本市場（エンドユーザー別）
  • リアルワールドエビデンスソリューションの日本市場：アプリケーション別
• インドのリアルワールドエビデンスソリューション市場
  • インドのリアルワールドエビデンスソリューション市場：コンポーネント別
  • インドのリアルワールドエビデンスソリューション市場（治療分野別）
  • インドのリアルワールドエビデンスソリューション市場（エンドユーザー別）
  • インドのリアルワールドエビデンスソリューション市場（用途別）
• 韓国のリアルワールドエビデンスソリューション市場
  • 韓国のリアルワールドエビデンスソリューション市場：コンポーネント別
  • 韓国のリアルワールドエビデンスソリューション市場（治療分野別）
  • 韓国のリアルワールドエビデンスソリューション市場（エンドユーザー別）
  • 韓国のリアルワールドエビデンスソリューション市場：用途別
• シンガポールのリアルワールドエビデンスソリューション市場
  • シンガポールのリアルワールドエビデンスソリューション市場：コンポーネント別
  • シンガポールのリアルワールドエビデンスソリューション市場（治療分野別）
  • シンガポールのリアルワールドエビデンスソリューション市場：エンドユーザー別
  • シンガポールのリアルワールドエビデンスソリューションの用途別市場
• マレーシアのリアルワールドエビデンスソリューション市場
  • マレーシアのリアルワールドエビデンスソリューションズ市場：コンポーネント別
  • マレーシアのリアルワールドエビデンスソリューション市場：治療分野別
  • マレーシアのリアルワールドエビデンスソリューション市場：エンドユーザー別
  • マレーシアのリアルワールドエビデンスソリューション市場（用途別）
• その他のアジア太平洋地域のリアルワールドエビデンスソリューション市場
  • その他のアジア太平洋地域のリアルワールドエビデンスソリューション市場：コンポーネント別
  • その他のアジア太平洋地域のリアルワールドエビデンスソリューション市場（治療分野別）
  • その他のアジア太平洋地域のリアルワールドエビデンスソリューション市場：エンドユーザー別
  • その他のアジア太平洋地域のリアルワールドエビデンスソリューション市場：用途別

第9章：企業プロファイル

• IBM Corporation
• Oracle Corporation
• PPD, Inc.（Thermo Fisher Scientific, Inc.）
• UnitedHealth Group, Inc.（Optum, Inc.）
• Syneos Health, Inc.
• IQVIA Holdings, Inc.
• Medpace Holdings, Inc.
• ICON plc
• PerkinElmer, Inc.
• Parexel International Corporation（Phoenix Parentco, Inc.）

LIST OF TABLES

• TABLE 1 Asia Pacific Real World Evidence Solutions Market, 2018 - 2021, USD Million
• TABLE 2 Asia Pacific Real World Evidence Solutions Market, 2022 - 2028, USD Million
• TABLE 3 Asia Pacific Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
• TABLE 4 Asia Pacific Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
• TABLE 5 Asia Pacific Services Market by Country, 2018 - 2021, USD Million
• TABLE 6 Asia Pacific Services Market by Country, 2022 - 2028, USD Million
• TABLE 7 Asia Pacific Data Set Market by Country, 2018 - 2021, USD Million
• TABLE 8 Asia Pacific Data Set Market by Country, 2022 - 2028, USD Million
• TABLE 9 Asia Pacific Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
• TABLE 10 Asia Pacific Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
• TABLE 11 Asia Pacific Oncology Market by Country, 2018 - 2021, USD Million
• TABLE 12 Asia Pacific Oncology Market by Country, 2022 - 2028, USD Million
• TABLE 13 Asia Pacific Cardiology Market by Country, 2018 - 2021, USD Million
• TABLE 14 Asia Pacific Cardiology Market by Country, 2022 - 2028, USD Million
• TABLE 15 Asia Pacific Neurology Market by Country, 2018 - 2021, USD Million
• TABLE 16 Asia Pacific Neurology Market by Country, 2022 - 2028, USD Million
• TABLE 17 Asia Pacific Diabetes Market by Country, 2018 - 2021, USD Million
• TABLE 18 Asia Pacific Diabetes Market by Country, 2022 - 2028, USD Million
• TABLE 19 Asia Pacific Respiratory Market by Country, 2018 - 2021, USD Million
• TABLE 20 Asia Pacific Respiratory Market by Country, 2022 - 2028, USD Million
• TABLE 21 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
• TABLE 22 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
• TABLE 23 Asia Pacific Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
• TABLE 24 Asia Pacific Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
• TABLE 25 Asia Pacific Healthcare Companies Market by Country, 2018 - 2021, USD Million
• TABLE 26 Asia Pacific Healthcare Companies Market by Country, 2022 - 2028, USD Million
• TABLE 27 Asia Pacific Healthcare Payers Market by Country, 2018 - 2021, USD Million
• TABLE 28 Asia Pacific Healthcare Payers Market by Country, 2022 - 2028, USD Million
• TABLE 29 Asia Pacific Healthcare Providers Market by Country, 2018 - 2021, USD Million
• TABLE 30 Asia Pacific Healthcare Providers Market by Country, 2022 - 2028, USD Million
• TABLE 31 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
• TABLE 32 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
• TABLE 33 Asia Pacific Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
• TABLE 34 Asia Pacific Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
• TABLE 35 Asia Pacific Drug Development & Approvals Market by Country, 2018 - 2021, USD Million
• TABLE 36 Asia Pacific Drug Development & Approvals Market by Country, 2022 - 2028, USD Million
• TABLE 37 Asia Pacific Medical Device Development & Approvals Market by Country, 2018 - 2021, USD Million
• TABLE 38 Asia Pacific Medical Device Development & Approvals Market by Country, 2022 - 2028, USD Million
• TABLE 39 Asia Pacific Reimbursement/Coverage & Regulatory Decision Making Market by Country, 2018 - 2021, USD Million
• TABLE 40 Asia Pacific Reimbursement/Coverage & Regulatory Decision Making Market by Country, 2022 - 2028, USD Million
• TABLE 41 Asia Pacific Post Market Safety & Adverse Events Monitoring Market by Country, 2018 - 2021, USD Million
• TABLE 42 Asia Pacific Post Market Safety & Adverse Events Monitoring Market by Country, 2022 - 2028, USD Million
• TABLE 43 Asia Pacific Real World Evidence Solutions Market by Country, 2018 - 2021, USD Million
• TABLE 44 Asia Pacific Real World Evidence Solutions Market by Country, 2022 - 2028, USD Million
• TABLE 45 China Real World Evidence Solutions Market, 2018 - 2021, USD Million
• TABLE 46 China Real World Evidence Solutions Market, 2022 - 2028, USD Million
• TABLE 47 China Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
• TABLE 48 China Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
• TABLE 49 China Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
• TABLE 50 China Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
• TABLE 51 China Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
• TABLE 52 China Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
• TABLE 53 China Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
• TABLE 54 China Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
• TABLE 55 Japan Real World Evidence Solutions Market, 2018 - 2021, USD Million
• TABLE 56 Japan Real World Evidence Solutions Market, 2022 - 2028, USD Million
• TABLE 57 Japan Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
• TABLE 58 Japan Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
• TABLE 59 Japan Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
• TABLE 60 Japan Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
• TABLE 61 Japan Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
• TABLE 62 Japan Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
• TABLE 63 Japan Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
• TABLE 64 Japan Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
• TABLE 65 India Real World Evidence Solutions Market, 2018 - 2021, USD Million
• TABLE 66 India Real World Evidence Solutions Market, 2022 - 2028, USD Million
• TABLE 67 India Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
• TABLE 68 India Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
• TABLE 69 India Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
• TABLE 70 India Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
• TABLE 71 India Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
• TABLE 72 India Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
• TABLE 73 India Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
• TABLE 74 India Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
• TABLE 75 South Korea Real World Evidence Solutions Market, 2018 - 2021, USD Million
• TABLE 76 South Korea Real World Evidence Solutions Market, 2022 - 2028, USD Million
• TABLE 77 South Korea Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
• TABLE 78 South Korea Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
• TABLE 79 South Korea Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
• TABLE 80 South Korea Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
• TABLE 81 South Korea Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
• TABLE 82 South Korea Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
• TABLE 83 South Korea Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
• TABLE 84 South Korea Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
• TABLE 85 Singapore Real World Evidence Solutions Market, 2018 - 2021, USD Million
• TABLE 86 Singapore Real World Evidence Solutions Market, 2022 - 2028, USD Million
• TABLE 87 Singapore Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
• TABLE 88 Singapore Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
• TABLE 89 Singapore Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
• TABLE 90 Singapore Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
• TABLE 91 Singapore Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
• TABLE 92 Singapore Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
• TABLE 93 Singapore Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
• TABLE 94 Singapore Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
• TABLE 95 Malaysia Real World Evidence Solutions Market, 2018 - 2021, USD Million
• TABLE 96 Malaysia Real World Evidence Solutions Market, 2022 - 2028, USD Million
• TABLE 97 Malaysia Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
• TABLE 98 Malaysia Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
• TABLE 99 Malaysia Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
• TABLE 100 Malaysia Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
• TABLE 101 Malaysia Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
• TABLE 102 Malaysia Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
• TABLE 103 Malaysia Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
• TABLE 104 Malaysia Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
• TABLE 105 Rest of Asia Pacific Real World Evidence Solutions Market, 2018 - 2021, USD Million
• TABLE 106 Rest of Asia Pacific Real World Evidence Solutions Market, 2022 - 2028, USD Million
• TABLE 107 Rest of Asia Pacific Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
• TABLE 108 Rest of Asia Pacific Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
• TABLE 109 Rest of Asia Pacific Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
• TABLE 110 Rest of Asia Pacific Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
• TABLE 111 Rest of Asia Pacific Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
• TABLE 112 Rest of Asia Pacific Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
• TABLE 113 Rest of Asia Pacific Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
• TABLE 114 Rest of Asia Pacific Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
• TABLE 115 Key information - IBM Corporation
• TABLE 116 Key Information - Oracle Corporation
• TABLE 117 Key Information - PPD, Inc.
• TABLE 118 Key Information - UnitedHealth Group, Inc.
• TABLE 119 Key Information - Syneos Health, Inc.
• TABLE 120 Key information - IQVIA Holdings, Inc.
• TABLE 121 key Information - Medpace Holdings, Inc.
• TABLE 122 key Information - PerkinElmer, Inc.
• TABLE 123 Key Information - PAREXEL International Corporation

List of Figures

• FIG 1 Methodology for the research
• FIG 2 Swot analysis: IBM Corporation
• FIG 3 SWOT analysis: Oracle Corporation
• FIG 4 Swot analysis: thermo fisher scientific, inc.

The Asia Pacific Real World Evidence Solutions Market would witness market growth of 9.0% CAGR during the forecast period (2022-2028).

The major pharmaceutical companies use a clinico-genomic database containing tumor sequencing data for cancer discovery investigations and the development of targeted drugs. As a result, businesses are able to perform a modest number of clinical trials for the uncommon biomarker-defined group while also expanding their range of indications. Thus, it shows that the market for real-world evidence solutions will rise in the coming years.

RWE can add patient-generated data, like biometric data or patient-reported outcomes (PROs), that is simpler to obtain between doctor visits to traditional outcome measurements during clinical studies. RWE is able to monitor quality and result metrics across organizations. For example, RWE can notify administrators of the benchmarking performance of their physicians and the performance of their overall health system compared to others.

This information can improve quality-based reimbursement schemes that honor good results and can assist payers and consumers in having more informed coverage discussions. Clinical registries, like the patient, product, and claims registries, are rich sources of RWD addition to that. They are essential resources for producing RWE and utilizing it to facilitate post-market investigation and surveillance.

Using RWE for regulatory & reimbursement decision-making is a journey that governments and regulators around the Asia Pacific are at various levels of. To show RWE's advantages and capabilities, some have already released formal advice and are moving on with pilot projects. Others are still in the initial phases of those approaches. Due to China's growing need for empirical data to support healthcare decisions, many new data sources have developed. Health economics, epidemiology, and outcomes research have not comprehensively assessed the real-world healthcare data sources that are currently available. Thus, the increased utilization of real world evidence in healthcare sector is driving the growth of Asia Pacific real world evidence solutions market.

The China market dominated the Asia Pacific Real World Evidence Solutions Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $4,657.7 million by 2028.The Japan market is estimated to grow a CAGR of 8.4% during (2022 - 2028). Additionally, The India market would experience a CAGR of 9.7% during (2022 - 2028).

Based on Component, the market is segmented into Services and Data Set. Based on Therapeutic Area, the market is segmented into Oncology, Cardiology, Neurology, Diabetes, Respiratory and Others. Based on End-user, the market is segmented into Healthcare Companies, Healthcare Payers, Healthcare Providers and Others. Based on Application, the market is segmented into Drug Development & Approvals, Medical Device Development & Approvals, Reimbursement/Coverage & Regulatory Decision Making and Post Market Safety & Adverse Events Monitoring. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include IBM Corporation, Oracle Corporation, Medpace Holdings, Inc., IQVIA Holdings, Inc., ICON plc, PerkinElmer, Inc., Parexel International Corporation (Phoenix Parentco, Inc.), PPD, Inc. (Thermo Fisher Scientific, Inc.), UnitedHealth Group, Inc. (Optum, Inc.), and Syneos Health, Inc.

Scope of the Study

Market Segments covered in the Report:

By Component

• Services
• Data Set

By Therapeutic Area

• Oncology
• Cardiology
• Neurology
• Diabetes
• Respiratory
• Others

By End-user

• Healthcare Companies
• Healthcare Payers
• Healthcare Providers
• Others

By Application

• Drug Development & Approvals
• Medical Device Development & Approvals
• Reimbursement/Coverage & Regulatory Decision Making
• Post Market Safety & Adverse Events Monitoring

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Companies Profiled

• IBM Corporation
• Oracle Corporation
• Medpace Holdings, Inc.
• IQVIA Holdings, Inc.
• ICON plc
• PerkinElmer, Inc.
• Parexel International Corporation (Phoenix Parentco, Inc.)
• PPD, Inc. (Thermo Fisher Scientific, Inc.)
• UnitedHealth Group, Inc. (Optum, Inc.)
• Syneos Health, Inc.

Unique Offerings from KBV Research

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Asia Pacific Real World Evidence Solutions Market, by Component
  • 1.4.2 Asia Pacific Real World Evidence Solutions Market, by Therapeutic Area
  • 1.4.3 Asia Pacific Real World Evidence Solutions Market, by End-user
  • 1.4.4 Asia Pacific Real World Evidence Solutions Market, by Application
  • 1.4.5 Asia Pacific Real World Evidence Solutions Market, by Country
• 1.5 Methodology for the research

Chapter 2. Market Overview

• 2.1 Introduction
  • 2.1.1 Overview
    • 2.1.1.1 Market Scenario and Composition
• 2.2 Key Factors Impacting the Market
  • 2.2.1 Market Drivers
  • 2.2.2 Market Restraints

Chapter 3. Strategies Deployed in Real World Evidence Solutions Market

Chapter 4. Asia Pacific Real World Evidence Solutions Market by Component

• 4.1 Asia Pacific Services Market by Country
• 4.2 Asia Pacific Data Set Market by Country

Chapter 5. Asia Pacific Real World Evidence Solutions Market by Therapeutic Area

• 5.1 Asia Pacific Oncology Market by Country
• 5.2 Asia Pacific Cardiology Market by Country
• 5.3 Asia Pacific Neurology Market by Country
• 5.4 Asia Pacific Diabetes Market by Country
• 5.5 Asia Pacific Respiratory Market by Country
• 5.6 Asia Pacific Others Market by Country

Chapter 6. Asia Pacific Real World Evidence Solutions Market by End-user

• 6.1 Asia Pacific Healthcare Companies Market by Country
• 6.2 Asia Pacific Healthcare Payers Market by Country
• 6.3 Asia Pacific Healthcare Providers Market by Country
• 6.4 Asia Pacific Others Market by Country

Chapter 7. Asia Pacific Real World Evidence Solutions Market by Application

• 7.1 Asia Pacific Drug Development & Approvals Market by Country
• 7.2 Asia Pacific Medical Device Development & Approvals Market by Country
• 7.3 Asia Pacific Reimbursement/Coverage & Regulatory Decision Making Market by Country
• 7.4 Asia Pacific Post Market Safety & Adverse Events Monitoring Market by Country

Chapter 8. Asia Pacific Real World Evidence Solutions Market by Country

• 8.1 China Real World Evidence Solutions Market
  • 8.1.1 China Real World Evidence Solutions Market by Component
  • 8.1.2 China Real World Evidence Solutions Market by Therapeutic Area
  • 8.1.3 China Real World Evidence Solutions Market by End-user
  • 8.1.4 China Real World Evidence Solutions Market by Application
• 8.2 Japan Real World Evidence Solutions Market
  • 8.2.1 Japan Real World Evidence Solutions Market by Component
  • 8.2.2 Japan Real World Evidence Solutions Market by Therapeutic Area
  • 8.2.3 Japan Real World Evidence Solutions Market by End-user
  • 8.2.4 Japan Real World Evidence Solutions Market by Application
• 8.3 India Real World Evidence Solutions Market
  • 8.3.1 India Real World Evidence Solutions Market by Component
  • 8.3.2 India Real World Evidence Solutions Market by Therapeutic Area
  • 8.3.3 India Real World Evidence Solutions Market by End-user
  • 8.3.4 India Real World Evidence Solutions Market by Application
• 8.4 South Korea Real World Evidence Solutions Market
  • 8.4.1 South Korea Real World Evidence Solutions Market by Component
  • 8.4.2 South Korea Real World Evidence Solutions Market by Therapeutic Area
  • 8.4.3 South Korea Real World Evidence Solutions Market by End-user
  • 8.4.4 South Korea Real World Evidence Solutions Market by Application
• 8.5 Singapore Real World Evidence Solutions Market
  • 8.5.1 Singapore Real World Evidence Solutions Market by Component
  • 8.5.2 Singapore Real World Evidence Solutions Market by Therapeutic Area
  • 8.5.3 Singapore Real World Evidence Solutions Market by End-user
  • 8.5.4 Singapore Real World Evidence Solutions Market by Application
• 8.6 Malaysia Real World Evidence Solutions Market
  • 8.6.1 Malaysia Real World Evidence Solutions Market by Component
  • 8.6.2 Malaysia Real World Evidence Solutions Market by Therapeutic Area
  • 8.6.3 Malaysia Real World Evidence Solutions Market by End-user
  • 8.6.4 Malaysia Real World Evidence Solutions Market by Application
• 8.7 Rest of Asia Pacific Real World Evidence Solutions Market
  • 8.7.1 Rest of Asia Pacific Real World Evidence Solutions Market by Component
  • 8.7.2 Rest of Asia Pacific Real World Evidence Solutions Market by Therapeutic Area
  • 8.7.3 Rest of Asia Pacific Real World Evidence Solutions Market by End-user
  • 8.7.4 Rest of Asia Pacific Real World Evidence Solutions Market by Application

Chapter 9. Company Profiles

• 9.1 IBM Corporation
  • 9.1.1 Company Overview
  • 9.1.2 Financial Analysis
  • 9.1.3 Regional & Segmental Analysis
  • 9.1.4 Research & Development Expenses
  • 9.1.5 Recent strategies and developments:
    • 9.1.5.1 Acquisition and Mergers:
  • 9.1.6 SWOT Analysis
• 9.2 Oracle Corporation
  • 9.2.1 Company Overview
  • 9.2.2 Financial Analysis
  • 9.2.3 Segmental and Regional Analysis
  • 9.2.4 Research & Development Expense
  • 9.2.5 SWOT Analysis
• 9.3 PPD, Inc. (Thermo Fisher Scientific, Inc.)
  • 9.3.1 Company Overview
  • 9.3.2 Financial Analysis
  • 9.3.3 Segmental and Regional Analysis
  • 9.3.4 Research & Development Expense
  • 9.3.5 SWOT Analysis
• 9.4 UnitedHealth Group, Inc. (Optum, Inc.)
  • 9.4.1 Company Overview
  • 9.4.2 Financial Analysis
  • 9.4.3 Segmental Analysis
• 9.5 Syneos Health, Inc.
  • 9.5.1 Company Overview
  • 9.5.2 Financial Analysis
  • 9.5.3 Segmental and Regional Analysis
  • 9.5.4 Recent strategies and developments:
    • 9.5.4.1 Acquisition and Mergers:
• 9.6 IQVIA Holdings, Inc.
  • 9.6.1 Company Overview
  • 9.6.2 Financial Analysis
  • 9.6.3 Segmental and Regional Analysis
  • 9.6.4 Recent strategies and developments:
    • 9.6.4.1 Partnerships, Collaborations, and Agreements:
    • 9.6.4.2 Acquisition and Mergers:
• 9.7 Medpace Holdings, Inc.
  • 9.7.1 Company Overview
  • 9.7.2 Financial Analysis
• 9.8 ICON plc
  • 9.8.1 Company Overview
  • 9.8.2 Financial Analysis
  • 9.8.3 Regional Analysis
  • 9.8.4 Recent strategies and developments:
    • 9.8.4.1 Acquisition and Mergers:
• 9.9 PerkinElmer, Inc.
  • 9.9.1 Company Overview
  • 9.9.2 Financial Analysis
  • 9.9.3 Segmental and Regional Analysis
  • 9.9.4 Research & Development Expense
  • 9.9.5 Recent strategies and developments:
    • 9.9.5.1 Product Launches and Product Expansions:
• 9.10. Parexel International Corporation (Phoenix Parentco, Inc.)
  • 9.10.1 Company Overview
  • 9.10.2 Recent strategies and developments:
    • 9.10.2.1 Partnerships, Collaborations, and Agreements: